Homocysteine levels impact directly on epigenetic reprogramming in astrocytes

Although the neurotoxic effects of homocysteine have been well elucidated, the effects of homocysteine in astrocytes have received little attention until recently. Previously we have demonstrated that elevated levels of homocysteine caused significant metabolic changes and altered mitochondrial function in primary cultures of astrocytes. However, the mechanisms behind such alterations remain unclear. As homocysteine is a key metabolite in one-carbon metabolism the present study examined if the effects of homocysteine on astrocyte function are mediated through an epigenetic mechanism. Following exposure to homocysteine for 72 h, global DNA methylation and H3K9 acetylation were examined using flow cytometric analysis. Total DNA methyltransferase activity and protein levels of DNA methyltransferase 3B were measured. Exposure to homocysteine resulted in global DNA hypomethylation (p < 0.05) and histone hyperacetylation (p < 0.05). Total DNA methyltransferase activity significantly decreased following exposure to homocysteine (from 11.5 ± 3.9 to 6.0 ± 1.7 OD/h/mg protein, p < 0.01) which was accompanied by a significant reduction in protein levels of DNA methyltransferase 3B (p < 0.05). Treatment of astrocytes with the DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine, mimicked the functional changes induced by homocysteine. In conclusion, the results demonstrate significant epigenetic modifications following exposure to homocysteine in astrocytes and these changes seem to mediate functional alterations.

► Exposure of astrocytes to homocysteine results in DNA hypomethylation.
► Exposure of astrocytes to homocysteine results in global histone hyperacetylation.
► Homocysteine exposure alters epigenetic signature of astrocytes.